Last reviewed · How we verify

NCT05481710

Nociplastic Pain in Patients With Chronic Shoulder Pain

Completed Last updated 12 June 2025
What this trial tests

trial testing Nociplastic Pain Criteria in Chronic Shoulder Pain in 70 participants. Completed in 10 January 2025.

Timeline
18 July 2022
Primary endpoint
10 January 2025
10 January 2025

Quick facts

Lead sponsorParaskevi Bilika
StatusCompleted
Study typeOBSERVATIONAL
Enrollment70
Start date18 July 2022
Primary completion10 January 2025
Estimated completion10 January 2025
Sites2 locations across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Paraskevi Bilika

Who can join

Adults 18 to 65, any sex, with Chronic Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to investigate predictors of nociplastic shoulder pain. Factors of psychological distress, functionality, fitness, quality of life, quality of sleep, functioning of the parasympathetic system, and lifestyle will be examined. Patients with nociplastic pain will be identified using the classification system proposed by the IASP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Shoulder Pain

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05481710.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing